The prevalence of AstraZeneca COVID-19 vaccine side effects among Nigist Eleni Mohammed memorial comprehensive specialized hospital health workers. Cross sectional survey.
<h4>Introduction</h4>The best way to eradicate corona virus disease (COVID-19) viral infection is mass vaccination. Many studies demonstrate vaccination is associated with some local and systemic side effects. This study aimed to provide evidence on AstraZeneca COVID-19 vaccine side effe...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2022-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0265140 |
| _version_ | 1811217452371017728 |
|---|---|
| author | Mitiku Desalegn Gelana Garoma Habtamu Tamrat Adane Desta Ajay Prakash |
| author_facet | Mitiku Desalegn Gelana Garoma Habtamu Tamrat Adane Desta Ajay Prakash |
| author_sort | Mitiku Desalegn |
| collection | DOAJ |
| description | <h4>Introduction</h4>The best way to eradicate corona virus disease (COVID-19) viral infection is mass vaccination. Many studies demonstrate vaccination is associated with some local and systemic side effects. This study aimed to provide evidence on AstraZeneca COVID-19 vaccine side effects.<h4>Methodology</h4>Institutional based cross-sectional survey was conducted among 254 health workers at Nigist Eleni Mohammed memorial comprehensive specialized hospital (from July 01/ 2021 to July 30/2021). Data were collected consecutively through self-administered online survey created on Google Forms of platform which had been randomly delivered via (Facebook or telegram pages). Demographic data of participants, side effect after first and second dose of vaccine were covered.<h4>Result</h4>The prevalence of at least one side effect after first dose was 91.3% and after second dose was 67%. Injection site pain (63.8% vs. 50.4%), headache (48.8% vs. 33.5%), fever (38.8% vs. 20.9%), muscle pain (38.8% vs. 21.7%), fatigue (26% vs. 28.7%, tenderness at the site (27.6% vs. 21.7%), and joint pain (27.6% vs. 20.9%) were the most commonly reported side effects after first and second dose vaccine respectively. Most of participants reported that their symptoms emerged after 6hr of vaccination and only less than 5% of participant's symptoms lasted more than 72hr of post vaccination. The younger age (≤29 year) were more susceptible to at least one side effect (χ 2 = 4.2; p = 0.04) after first dose.<h4>Conclusion</h4>The prevalence of side effect after first and second dose vaccine was higher. Most of the symptoms were short lived and mild. This result might help to solve an emerging public health challenge (vaccine hesitancy) nurtured by misinformation related to vaccines safety. |
| first_indexed | 2024-04-12T06:55:02Z |
| format | Article |
| id | doaj.art-986da28ba58f4d1e9dab155a08173ae2 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-04-12T06:55:02Z |
| publishDate | 2022-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-986da28ba58f4d1e9dab155a08173ae22022-12-22T03:43:11ZengPublic Library of Science (PLoS)PLoS ONE1932-62032022-01-01176e026514010.1371/journal.pone.0265140The prevalence of AstraZeneca COVID-19 vaccine side effects among Nigist Eleni Mohammed memorial comprehensive specialized hospital health workers. Cross sectional survey.Mitiku DesalegnGelana GaromaHabtamu TamratAdane DestaAjay Prakash<h4>Introduction</h4>The best way to eradicate corona virus disease (COVID-19) viral infection is mass vaccination. Many studies demonstrate vaccination is associated with some local and systemic side effects. This study aimed to provide evidence on AstraZeneca COVID-19 vaccine side effects.<h4>Methodology</h4>Institutional based cross-sectional survey was conducted among 254 health workers at Nigist Eleni Mohammed memorial comprehensive specialized hospital (from July 01/ 2021 to July 30/2021). Data were collected consecutively through self-administered online survey created on Google Forms of platform which had been randomly delivered via (Facebook or telegram pages). Demographic data of participants, side effect after first and second dose of vaccine were covered.<h4>Result</h4>The prevalence of at least one side effect after first dose was 91.3% and after second dose was 67%. Injection site pain (63.8% vs. 50.4%), headache (48.8% vs. 33.5%), fever (38.8% vs. 20.9%), muscle pain (38.8% vs. 21.7%), fatigue (26% vs. 28.7%, tenderness at the site (27.6% vs. 21.7%), and joint pain (27.6% vs. 20.9%) were the most commonly reported side effects after first and second dose vaccine respectively. Most of participants reported that their symptoms emerged after 6hr of vaccination and only less than 5% of participant's symptoms lasted more than 72hr of post vaccination. The younger age (≤29 year) were more susceptible to at least one side effect (χ 2 = 4.2; p = 0.04) after first dose.<h4>Conclusion</h4>The prevalence of side effect after first and second dose vaccine was higher. Most of the symptoms were short lived and mild. This result might help to solve an emerging public health challenge (vaccine hesitancy) nurtured by misinformation related to vaccines safety.https://doi.org/10.1371/journal.pone.0265140 |
| spellingShingle | Mitiku Desalegn Gelana Garoma Habtamu Tamrat Adane Desta Ajay Prakash The prevalence of AstraZeneca COVID-19 vaccine side effects among Nigist Eleni Mohammed memorial comprehensive specialized hospital health workers. Cross sectional survey. PLoS ONE |
| title | The prevalence of AstraZeneca COVID-19 vaccine side effects among Nigist Eleni Mohammed memorial comprehensive specialized hospital health workers. Cross sectional survey. |
| title_full | The prevalence of AstraZeneca COVID-19 vaccine side effects among Nigist Eleni Mohammed memorial comprehensive specialized hospital health workers. Cross sectional survey. |
| title_fullStr | The prevalence of AstraZeneca COVID-19 vaccine side effects among Nigist Eleni Mohammed memorial comprehensive specialized hospital health workers. Cross sectional survey. |
| title_full_unstemmed | The prevalence of AstraZeneca COVID-19 vaccine side effects among Nigist Eleni Mohammed memorial comprehensive specialized hospital health workers. Cross sectional survey. |
| title_short | The prevalence of AstraZeneca COVID-19 vaccine side effects among Nigist Eleni Mohammed memorial comprehensive specialized hospital health workers. Cross sectional survey. |
| title_sort | prevalence of astrazeneca covid 19 vaccine side effects among nigist eleni mohammed memorial comprehensive specialized hospital health workers cross sectional survey |
| url | https://doi.org/10.1371/journal.pone.0265140 |
| work_keys_str_mv | AT mitikudesalegn theprevalenceofastrazenecacovid19vaccinesideeffectsamongnigistelenimohammedmemorialcomprehensivespecializedhospitalhealthworkerscrosssectionalsurvey AT gelanagaroma theprevalenceofastrazenecacovid19vaccinesideeffectsamongnigistelenimohammedmemorialcomprehensivespecializedhospitalhealthworkerscrosssectionalsurvey AT habtamutamrat theprevalenceofastrazenecacovid19vaccinesideeffectsamongnigistelenimohammedmemorialcomprehensivespecializedhospitalhealthworkerscrosssectionalsurvey AT adanedesta theprevalenceofastrazenecacovid19vaccinesideeffectsamongnigistelenimohammedmemorialcomprehensivespecializedhospitalhealthworkerscrosssectionalsurvey AT ajayprakash theprevalenceofastrazenecacovid19vaccinesideeffectsamongnigistelenimohammedmemorialcomprehensivespecializedhospitalhealthworkerscrosssectionalsurvey AT mitikudesalegn prevalenceofastrazenecacovid19vaccinesideeffectsamongnigistelenimohammedmemorialcomprehensivespecializedhospitalhealthworkerscrosssectionalsurvey AT gelanagaroma prevalenceofastrazenecacovid19vaccinesideeffectsamongnigistelenimohammedmemorialcomprehensivespecializedhospitalhealthworkerscrosssectionalsurvey AT habtamutamrat prevalenceofastrazenecacovid19vaccinesideeffectsamongnigistelenimohammedmemorialcomprehensivespecializedhospitalhealthworkerscrosssectionalsurvey AT adanedesta prevalenceofastrazenecacovid19vaccinesideeffectsamongnigistelenimohammedmemorialcomprehensivespecializedhospitalhealthworkerscrosssectionalsurvey AT ajayprakash prevalenceofastrazenecacovid19vaccinesideeffectsamongnigistelenimohammedmemorialcomprehensivespecializedhospitalhealthworkerscrosssectionalsurvey |